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Horizontal gene transfer converts non-toxigenic
Clostridium difﬁcile strains into toxin producers
Michael S.M. Brouwer1, Adam P. Roberts1, Haitham Hussain1, Rachel J. Williams1,
Elaine Allan1 & Peter Mullany1
Clostridium difﬁcile is a major nosocomial pathogen and the main causative agent of antibiotic-
associated diarrhoea. The organism produces two potent toxins, A and B, which are its major
virulence factors. These are chromosomally encoded on a region termed the pathogenicity
locus (PaLoc), which also contains regulatory genes, and is absent in non-toxigenic strains.
Here we show that the PaLoc can be transferred from the toxin-producing strain, 630Derm, to
three non-toxigenic strains of different ribotypes. One of the transconjugants is shown by
cytotoxicity assay to produce toxin B at a similar level to the donor strain, demonstrating that
a toxigenic C. difﬁcile strain is capable of converting a non-toxigenic strain to a toxin producer
by horizontal gene transfer. This has implications for the treatment of C. difﬁcile infections, as
non-toxigenic strains are being tested as treatments in clinical trials.
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C lostridium difﬁcile-associated diarrhoea (CDAD) canrange from mild to severe and can be fatal due tocomplications such as pseudomembranous colitis and
toxic megacolon1. CDAD is almost always associated with
antibiotic usage, which disrupts the normal gut microﬂora
allowing C. difﬁcile colonization2. The organism produces two
potent toxins, A and B, which disrupt the gut epithelium and are
the major virulence factors of this organism3,4. Both toxins are
encoded on the pathogenicity locus (PaLoc), a 19.6-kb
chromosomal region that also encodes potential transcriptional
regulators and a holin-like protein. The entire PaLoc is absent
from non-toxigenic strains replaced by a highly conserved 115 bp
non-coding region at this genomic site5.
C. difﬁcile 630Derm6 is an erythromycin-sensitive derivative of
the toxigenic C. difﬁcile 630 (ref. 7) and contains the PaLoc3,4.
This strain also contains at least six active conjugative
transposons (CTns), genetic elements that are generally
integrated into the genome but are capable of mediating their
own transfer to suitable recipients8. Conjugative transfer was
shown for CTn1, CTn2, CTn4, CTn5, CTn7 and Tn5397, all of
which can be transferred to the non-toxigenic C. difﬁcile strain
CD37 (refs 9–11). The aim of the current investigation was to
determine if any other genetic information is cotransferred with
the CTns. We demonstrate that the PaLoc can be transferred to
CD37, which results in this non-toxigenic strain being converted
to a toxin producer.
Results
The PaLoc transfers to non-toxigenic C. difﬁcile CD37. To
determine whether genetic elements were cotransferred in the
absence of direct selection when transfer of CTn1 was selected, we
initially investigated nine CD37 transconjugants containing
CTn1::ermB (an erythromycin-resistant derivative of CTn1
(ref. 9)) by PCR and subsequent DNA sequencing (see Methods
section for details). One of these strains had unexpectedly
acquired the PaLoc. To determine whether the PaLoc could
transfer independently of CTn1, strain 630Derm tcdB::erm(B)
(Table 1)4 containing a genetically marked PaLoc was used
as a donor with CD37 as the recipient. PaLoc-containing trans-
conjugants were obtained at a frequency of 7.5 10 9
transconjugants per donor (s.d.¼ 4.2 10 9), comparable to
transfer frequencies previously reported for other CTns that are
transferred between these strains9.
It is important to determine whether the newly acquired toxin
genes are capable of directing toxin production. To do this, one of
the PaLoc-containing transconjugants that had acquired the wild-
type PaLoc (that is, one of the transconjugants that contained
CTn1 and the PaLoc) was selected for further study and
designated PaLoc386 (Table 1). This strain was subject to an
in vitro cytotoxicity assay with HFF-1 cells. Filter-sterilized cell
supernatants were incubated with a monolayer of HFF-1 cells for
24 h before the cytopathic effect (CPE) was determined (Fig. 1a).
The end point toxin titre4 was determined for 630Derm,
PaLoc386 and CD37 (Fig. 1c). PaLoc386 produced similar levels
of toxin to the donor strain 630Derm, whereas supernatant from
the recipient strain CD37 was negative for toxin production
(Fig. 1c). Addition of a commercial TcdB antiserum (see
Methods) abolished the CPE of both the 630Derm and PaLoc386
supernatants indicating that the two strains produced functional
toxin B (Fig. 1c).
The PaLoc is transferred on variable-sized DNA fragments. To
investigate the mechanism underlying the PaLoc transfer, whole-
genome sequences were determined for seven transconjugants
containing either the marked or wild-type PaLoc. The sequence of
the PaLoc in strain PaLoc386 was identical to that of the donor.
In the other transconjugants, the PaLoc contained the clostron
insertion, but was otherwise identical to the PaLoc in 630Derm.
To deﬁne the horizontally transferred region in the transconju-
gants, it was necessary to distinguish between donor and recipient
genome. To do this, 30 regions of B10 kb evenly spaced around
the 630Derm genome were selected (shown schematically in Fig. 2
as green bars with the sequences given in SI1) and compared with
the corresponding regions of the CD37 genome12. These regions
were chosen as they did not contain any predicted mobile genetic
elements such as CTns, IStrons or prophages. The presence of
10–150 single-nucleotide polymorphisms (SNPs) and indels in
these 30 regions allowed discrimination between the donor and
recipient DNA. Alignment of the genomic DNA sequence of the
PaLoc-containing transconjugants in the 30 regions showed that
in all cases, regions 1–3 and 8–30 were derived from the recipient.
In the donor strains, 630Derm and 630Derm tcdB::erm(B), and in
all of the transconjugants, the PaLoc is located between regions 6
and 7. In the transconjugants, the PaLoc has transferred on
variable-sized DNA fragments that include either region 6 or 7
from the donor strain in 6 out of 7 transconjugants, and regions 5
and 6 from the donor in transconjugant PaLoc385. In transcon-
jugant PaLoc26, the PaLoc was transferred from the donor on a
relatively small DNA fragment (a maximum size of 67,644 bp)
and both regions 6 and 7 in this transconjugant are derived from
the recipient. In transconjugants, PaLoc386 and PaLoc37, Tn5397
and the PaLoc have transferred on the same DNA fragment
(Fig. 2). This contrasts with the other cotransfers where the CTn
and the PaLoc transferred on separate DNA fragments. For
example, in transconjugant PaLoc386, CTn5 also transferred but
Table 1 | Bacterial strains used in this study.
Strain (Ribotype) Properties Reference
or source
630 (012) TcR ErmR RifS 26
630Derm (012) TcR ErmS RifS 6
CD37 (009) TcS ErmS RifR non-toxigenic 27
CD843 Positive control for jC630-1 and
jC630-2
28
630Derm CTn1
CD0386::erm(B)
(012)
ClosTron mutant, donor of CTn1,
erm(B) present in CD0386 within CTn1
9
630Derm
tcdB::erm(B) (012)
ClosTron mutant, contains erm(B)
inserted within tcdB
4
OX904 (138) Non-toxigenic recent clinical isolate 13
OX2157 (140) Non-toxigenic recent clinical isolate 13
OX904rif (138) Rifampicin-resistant derivative of
OX904
This study
OX2157rif (140) Rifampicin-resistant derivative of
OX2157
This study
PaLoc386 CD37 transconjugant containing
the 630Derm wild-type PaLoc
This study
PaLoc12 CD37 transconjugant containing
the ClosTron tcdB::erm(B) PaLoc
This study
PaLoc22 CD37 transconjugant containing
the ClosTron tcdB::erm(B) PaLoc
This study
PaLoc26 CD37 transconjugant containing
the ClosTron tcdB::erm(B) PaLoc
This study
PaLoc35 CD37 transconjugant containing
the ClosTron tcdB::erm(B) PaLoc
This study
PaLoc37 CD37 transconjugant containing
the ClosTron tcdB::erm(B) PaLoc
This study
PaLoc46 CD37 transconjugant containing
the ClosTron tcdB::erm(B) PaLoc
This study
Erm, erythromycin; Rif, rifampicin; R, resistant; S, susceptible; Tc, tetracycline.
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independently of the PaLoc and has inserted near region 16
in the transconjugant (Fig. 2). In contrast to PaLoc transfer,
in which the ﬂanking DNA was also derived from the donor,
there was no evidence for the transfer of ﬂanking DNA in
the case of CTn5. The remaining PaLoc-containing transcon-
jugants shown in Fig. 2 did not contain CTn2, CTn4, CTn5,
CTn7 or Tn5397.
The approximate length of the transferred DNA in each of the
transconjugants was determined by calculating the distance from
the ﬁrst SNP or indel upstream of the PaLoc to the last SNP or
indel downstream of the PaLoc that was speciﬁc to the donor
strain 630Derm. Because of the high level of sequence identity
between CD37 and 630Derm in the regions ﬂanking the PaLoc,
this analysis could only determine the maximum and minimum
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Figure 1 | Cytotoxicity assay comparing toxin production. Toxin production by the donor, transconjugant and recipient strains were compared using a
cytotoxicity assay. (a) HFF-1 cells incubated with the culture supernatant of transconjugant PaLoc386 show rounding of the cells. (b) The cytotoxic
effect of PaLoc386 can be neutralized using antibodies against TcdB. Scale bar, 1mm in a and b. (c) The toxin end point titre was determined for culture
supernatants of donor strain 630 Derm, transconjugants PaLoc386 and the recipient CD37. The mean±s.d. is shown for three independent experiments.
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Figure 2 | Schematic representation of the donor-speciﬁc DNA fragments present in the transconjugants. The circular chromosome of C. difﬁcile strain
630 is shown. The boxed region on the left is magniﬁed on the right. The green fragments in the outer ring represent the 10 kb fragments used to
differentiate transconjugants from donors; see text for more details. The dark blue fragments in the second ring indicate the mobile genetic elements
present in the donor; the red fragment in this ring represents the PaLoc. The donor-speciﬁc fragments that are present in the transconjugants are shown in
the seven inner-most rings as coloured fragments with the number of each transconjugant indicated. The red fragments in these represent the
transferred PaLoc. The dark blue fragments in the track of PaLoc386 depict CTn1 and CTn5 that are both present in this transconjugant.
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size of the transferred fragment (Table 2, sequences included
in SI2). The PaLoc was transferred on variable-sized DNA
fragments ranging from at least 66,034 bp to a maximum of
272,977 bp (Table 2 and Fig. 2).
To exclude transformation as a mechanism of transfer, the
mating experiments were repeated in the presence of DNase and
no difference in the frequency of transfer was detected. It was also
possible that the PaLoc could be transferred by transduction by
either of the prophages that are present in strain 630Derm
(Fig. 2). We think this is improbable given that the transferred
DNA is much larger than the phage genomes and is unlikely
therefore to be packaged within the phage heads. Nonetheless
concentrated phage suspensions were made by mitomycin C
induction of 630Derm tcdB::erm(B). We attempted to infect strain
CD37 with these phage suspensions but did not obtain plaques,
indicating that this strain is resistant to these phages. Strain
CD843 was used to conﬁrm the presence of infectious phages in
the suspensions. Although plaques were produced with this host,
no lincomycin-resistant transductants were obtained in this
phage assay. These results indicate that PaLoc transfer is unlikely
to occur via transduction.
The PaLoc can transfer into other non-toxigenic strains. Recent
work by Dingle et al.13, analysing the molecular epidemiology of a
large population of C. difﬁcile strains, has suggested that PaLoc
transfer is occurring in wild populations. We tested two of the
non-toxigenic isolates from this study (OX904 belonging to clade
4, PCR-ribotype 138 and OX2157 belonging to clade 1, PCR-
ribotype 140) to determine whether they could act as recipients
for the marked PaLoc in matings using 630Derm tcdB::erm(B) as
donor. To do this, spontaneous rifampicin-resistant derivatives of
these strains were ﬁrst isolated (see Methods and Table 1). The
PaLoc was transferred to OX2157rif at a frequency of 4.4 10 8
and to OX904rif at a frequency of 2.3 10 9, indicating that
PaLoc transfer is not restricted to particular donor and recipient
pairs.
Discussion
This work demonstrates that the PaLoc of C. difﬁcile 630Derm is
capable of transfer by a conjugation-like mechanism to non-
toxigenic strains. In the case of C. difﬁcile CD37, we showed that
this resulted in its conversion to a toxin producer. This ﬁnding
has important clinical implications, as non-toxigenic strains have
shown promise as a treatment for CDAD14. Clearly, if the PaLoc
is capable of transfer to strains being used for treatment, then we
urgently need to understand the conditions under which transfer
of the PaLoc is selected. Non-toxigenic strains are found
coexisting with toxigenic ones13, providing opportunity for the
PaLoc to spread within the C. difﬁcile populations. Also of
concern is the ﬁnding that transfer of the PaLoc often, but not
always, occurs with cotransfer of conjugative transposons
encoding resistance to antibiotics, resulting in the cotransfer
of virulence and antibiotic-resistance genes. This is illustrated in
the transconjugants PaLoc386 and PaLoc37, in which Tn5397
(encoding tetracycline resistance) and the PaLoc were transferred
on the same DNA fragment from 630Derm to CD37. CTns and
the PaLoc can also be transferred on separate DNA fragments as
shown by transconjugant PaLoc386 in which CTn5 and CTn1 are
transferred and integrated into their preferred genomic
sites9 (between regions 15 and 16 for CTn5, and between
regions 3 and 4 for CTn1 (Fig. 2)) with no detectable transfer of
ﬂanking DNA. Presumably in this case, CTn5 and CTn1
transferred by excision to form a circular molecule that was
nicked at the origin of transfer (oriT) and transferred as a distinct
genetic element.
A striking observation is that although transfer of the PaLoc
and the CTns occurs at a low frequency (between 10 7 and 10 9
transconjugants per donor), cotransfer of unselected genetic
elements (including the PaLoc) is observed. A probable explana-
tion for this is that when one or more of the CTns initiates a
transfer event, other elements present in the same cell are
activated by trans-acting regulatory molecules. This type of
interaction has been observed between Tn916-like elements15.
The ﬁrst step in transfer by conjugative and mobilizable
transposons is excision to form a circular molecule that is
nicked at the oriT, and a single strand is transferred to a suitable
recipient via a mating pore in a complex process analogous to
type IV secretion16. However, the PaLoc is not contained within
an obvious mobile element and is transferred on DNA fragments
of variable size in different transconjugants. This type of transfer
is reminiscent of that mediated by high-frequency recombination
(Hfr) in which an oriT within the chromosome can mediate
transfer of the chromosome17. In the recipient, the incoming
chromosomal DNA is integrated into the chromosome by
homologous recombination. In theory, the whole chromosome
can be transferred, although this rarely happens due to disruption
of the mating pair or nicking of the incoming DNA strand, so
that markers proximal to the integrated oriT are transferred at a
higher frequency than those located distally. There are examples
of CTns mediating Hfr-type transfer, for example, in Vibrio
cholerae18 and Bacteroides sp.19 In these cases, the CTns do not
excise so that instead of just mobilizing themselves, the
chromosome is also mobilized. Three transfer-proﬁcient CTns
in the C. difﬁcile genome, CTn1, CTn2 and Tn5397 are close to
the PaLoc (Fig. 2) and are candidates for mediation of Hfr
transfer. The regions ﬂanking the PaLoc in 630Derm are
homologous to chromosomal DNA of the non-toxigenic strain,
CD37, and, consequently, the incoming DNA from the donor
could recombine with the recipient chromosome resulting in
integration of this region. Whole-genome sequence comparison
has indicated that large blocks of DNA have transferred between
C. difﬁcile strains in the past, indicating that this form of transfer
is an important driver of C. difﬁcile genome evolution20.
A recent study of diversity in the C. difﬁcile S-layer cassette
suggests that this cassette is undergoing horizontal gene transfer
across genotypes21. The recombination events for the cassette
shown in this study were signiﬁcantly smaller (12–35 kb) than
those reported here for the PaLoc, and the recombining loci are
located B2Mb apart on the chromosome. Although transfer of
the S-layer cassette has not been demonstrated, it is possible that
this region can transfer by a mechanism similar to that of the
PaLoc, a hypothesis that requires investigation.
Methods
Strains and growth conditions. All strains used in this study are listed in SI 3.
C. difﬁcile strains were grown in brain–heart infusion (BHI) broth or on BHI agar
Table 2 | Size of the DNA fragments inserted in the recipient
strain.
Isolate Minimum size of DNA
fragment transferred
Maximum size of DNA
fragment transferred
PaLoc386 271,992 bp 272,977 bp
PaLoc12 151,692 bp 155,024bp
PaLoc22 157,688bp 170,386 bp
PaLoc26 66,034 bp 67,644 bp
PaLoc35 224,973 bp 228,497 bp
PaLoc37 250,027 bp 252,009 bp
PaLoc46 141,658 bp 145,290bp
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(Oxoid Ltd, Basingstoke, UK) supplemented with 5% deﬁbrinated horse blood (E &
O laboratories, Bonnybridge, UK). For the cytotoxicity assay, C. difﬁcile was grown
in tryptone, yeast (TY) broth consisting of 3% Bacto Tryptose (BD Biosciences,
Oxford, UK), 2% yeast extract (Oxoid Ltd) and 0.1% thioglycolate (Sigma-Aldrich
Company Ltd, UK) at pH 7.4. C. difﬁcile strains were grown at 37 C under
anaerobic conditions (80% N2, 10% H2 and 10% CO2).
Molecular biology techniques. DNA was isolated using the Gentra Puregene
Yeast/Bact. Kit (Qiagen, UK). PCR ampliﬁcation was carried out using the NEB
Taq polymerase kit (New England Biolabs, UK) according to the manufacturer’s
instructions.
Filter-matings. Donor and recipient strains were grown in BHI broth to an OD600
of B0.5–0.6. Cells were washed, pellets were taken up into BHI broth and donor
and recipient cultures were mixed. The cell mixture was spread onto 0.45 mm pore
size cellulose nitrate ﬁlters (Sartorius, Epsom, UK) on BHI agar plates. In some
cases DNase was added to the mating plates at a concentration of 50 mgml 1.
After 24 h, the ﬁlters were placed in 25ml tubes containing 1ml BHI broth and
were vortexed vigorously. The cell mixture was spread onto selective plates to
determine donor, recipient and transconjugant cell numbers on the ﬁlters.
Putative transconjugants were assessed by PCR for the presence of the erm(B)
selection marker using primers ErmRAM-F (50-ACGCGTTATATTGATAAAAA
TAATAATAGTGGG-30) and ErmRAM-R (50-ACGCGTGCGACTCATAGAATT
ATTTCCTCCCG-30)22. The presence of the PaLoc was determined by PCR
using primers tcdA-F (50-CATCTATAAGTTCTCATATTCCTTC-30) and tcdA-R
(50-CCAGAAACTTATATTGTCC-30). The absence of the CDT locus was
determined using primers cdtA-F (50-(C/T)AATACTACTTACAAGGCTCC-30)
and cdtA-R (50-TTTCGTTTTGATTTT(C/T)TGTTC-30). Spontaneous rifampicin-
resistant mutants were isolated by plating 1010 bacteria on agar plates containing
25mgml 1 rifampicin. As the complete genome sequence of strains OX904 and
OX2157 is not available, transconjugants were differentiated from spontaneous
rifampicin-resistant mutants of the donor by PCR and sequencing of genes cwp66
(primers 50AAACCWAHARYYAATGATACAG and 50RTWGWTYTTCCCCAT
CKWGAAAC) and gene CD25780 (primers 50GATGATATAGACTTTACATC
AGAAG and 50CAGCCGCAATTACTTTTAATC) encoding a predicted serine
threonine protein kinase.
Cytotoxicity assay. HFF-1 cells were grown in Dulbecco’s Modiﬁed Eagle Med-
ium (DMEM) (Life technologies) supplemented with 10% heat-inactivated fetal calf
serum, 2mM glutamine, 100 unitsml 1 penicillin and 100 mgml 1 streptomycin
at 37 C in 5% CO2. Cells were subcultured by washing twice with sterile PBS and
incubating with 0.1% trypsin for 5min. For the cytotoxicity assay, the cells were
seeded at 104 cells per well in 96-well plates and incubated for 24 h in 5% CO2.
Overnight C. difﬁcile cultures were diluted 1:10 into tryptone, yeast (TY) broth
and incubated without shaking for 48 h. The cultures were centrifuged for 10min at
4,500 g and the supernatant was ﬁlter-sterilized. A dilution series of the supernatant
was prepared in PBS. Each dilution was added to conﬂuent HFF-1 cells in
duplicate. After 24 h, the cells were assessed for CPE using an inverted microscope.
The toxin end point titre was recorded as the lowest dilution in the series where the
cells were indistinguishable from the negative control. C. difﬁcile antitoxin (C.
difﬁcile test kit, T5003Techlab Inc, Blacksburg, VA, USA) was added to one of the
duplicate wells to determine whether the CPE was neutralized.
Genomic sequencing. Genomic sequencing was performed by UCL Genomics as
part of a 72-bp paired end run, performed on an Illumina GAII-X. Genome
assembly was performed using the Velvet software suite23 and reads were mapped
against strain 630 (AM180355) using xBase24. The transconjugant sequences were
compared with the sequence of strain 630 (AM180355) and the shotgun sequence
of strain CD37 (AHJJ01000000) using the Artemis Comparison Tool25. SNP
analysis was performed by alignment using eBioX version 1.51. Sequence of the
chromosomal DNA used to compare the donor- and recipient-speciﬁc DNA in the
transconjugants is provided in Supplementary Data 1. Sequence at the junctions
between the chromosome and the donor-speciﬁc fragment is provided in
Supplementary Data 2. The ends on either side of the transferred fragment are
compared with the donor and recipient sequences.
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